Filing Details
- Accession Number:
- 0001447362-20-000287
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-14 14:04:54
- Reporting Period:
- 2020-12-10
- Accepted Time:
- 2020-12-14 14:04:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447362 | Castle Biosciences Inc | CSTL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239501 | J Derek Maetzold | C/O Castle Biosciences, Inc. 820 S. Friendswood Drive, Suite 201 Friendswood TX 77546 | Pres. & Chief Exec. Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-12-10 | 700 | $57.14 | 1,335,302 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-10 | 14,300 | $59.02 | 1,321,002 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-11 | 3,423 | $58.69 | 1,317,579 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-11 | 9,255 | $59.72 | 1,308,324 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-11 | 2,120 | $60.65 | 1,306,204 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-11 | 202 | $61.79 | 1,306,002 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Acquisiton | 2020-12-10 | 87,100 | $0.00 | 87,100 | $59.16 |
| Common Stock | Restricted Stock Units | Acquisiton | 2020-12-10 | 21,450 | $0.00 | 21,450 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 87,100 | 2030-12-09 | No | 4 | A | Direct | |
| 21,450 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 159,329 | Indirect | By trust |
Footnotes
- These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020.
- This transaction was executed in multiple trades at prices ranging from $56.800 to $57.610, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $58.230 to $59.225, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $58.120 to $59.100, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $59.190 to $60.120, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $60.320 to $61.300, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $61.325 to $62.010, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Held by the DJM Grantor Retained Annuity Trust No. 1, or the Maetzold Trust. The Reporting Person is a trustee of the Maetzold Trust.
- 25% of shares shall vest on December 10, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter.
- Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- The RSUs vest in four equal annual installments beginning on December 10, 2021.
Billionaire Hedge Funds
